2017 was a busy year for Endpoint Outcomes.  We continued our extensive instrument development activities to support sponsors in developing labeling claims with COAs. We cruised through our 2,500th patient interview and are well on our way to our 3,000th interview.  One of the most rewarding aspects to our work in 2017 was our research in rare/orphan diseases where we hear directly from patients and their caregivers on the major impacts that their diseases have on their daily lives.  We have also been active in innovative psychometric research and continue to expand our work in consensus generating techniques through Delphi panels to develop consensus recommendations and screening tools. Finally, it was our pleasure to work with Grace Cares and Project Hearts to help improve public health in the Dominican Republic.

Moving forward in 2018 we are looking at expanding our operations in Boston again and building up our psychometric team under the leadership of Dave Andrae. We look forward to seeing everyone at ISPOR, ISOQOL and C-Path in 2018.